C B Whitley

1.2k total citations
30 papers, 970 citations indexed

About

C B Whitley is a scholar working on Physiology, Epidemiology and Rheumatology. According to data from OpenAlex, C B Whitley has authored 30 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 9 papers in Epidemiology and 9 papers in Rheumatology. Recurrent topics in C B Whitley's work include Lysosomal Storage Disorders Research (19 papers), Glycogen Storage Diseases and Myoclonus (9 papers) and Trypanosoma species research and implications (8 papers). C B Whitley is often cited by papers focused on Lysosomal Storage Disorders Research (19 papers), Glycogen Storage Diseases and Myoclonus (9 papers) and Trypanosoma species research and implications (8 papers). C B Whitley collaborates with scholars based in United States, France and Czechia. C B Whitley's co-authors include Charyl M. Dutton, Joseph P. Neglia, Elena L. Aronovich, Robert J. Gorlin, Stephen E. Braun, Elsa Shapiro, Paul J. Orchard, Jakub Tolar, Filippo M. Santorelli and William Krivit and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Radiology.

In The Last Decade

C B Whitley

29 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C B Whitley United States 17 556 287 214 209 143 30 970
I Maire France 17 785 1.4× 341 1.2× 279 1.3× 287 1.4× 188 1.3× 85 1.2k
Shu-Chuan Chiang Taiwan 10 426 0.8× 208 0.7× 179 0.8× 197 0.9× 102 0.7× 20 721
Vũ Chí Dũng Vietnam 18 729 1.3× 298 1.0× 319 1.5× 222 1.1× 191 1.3× 38 1.1k
Esmée Oussoren Netherlands 15 383 0.7× 245 0.9× 169 0.8× 166 0.8× 77 0.5× 32 768
Motomichi Kosuga Japan 19 500 0.9× 239 0.8× 223 1.0× 179 0.9× 89 0.6× 54 839
J. E. Wraith United Kingdom 20 692 1.2× 381 1.3× 242 1.1× 434 2.1× 76 0.5× 35 1.3k
Yasutsugu Chinen Japan 15 371 0.7× 269 0.9× 165 0.8× 125 0.6× 97 0.7× 38 736
Ting‐Rong Hsu Taiwan 16 463 0.8× 201 0.7× 217 1.0× 178 0.9× 127 0.9× 53 780
R J Desnick United States 12 778 1.4× 245 0.9× 309 1.4× 212 1.0× 205 1.4× 20 941
Young Bae Sohn South Korea 19 402 0.7× 293 1.0× 235 1.1× 204 1.0× 96 0.7× 93 1.1k

Countries citing papers authored by C B Whitley

Since Specialization
Citations

This map shows the geographic impact of C B Whitley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C B Whitley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C B Whitley more than expected).

Fields of papers citing papers by C B Whitley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C B Whitley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C B Whitley. The network helps show where C B Whitley may publish in the future.

Co-authorship network of co-authors of C B Whitley

This figure shows the co-authorship network connecting the top 25 collaborators of C B Whitley. A scholar is included among the top collaborators of C B Whitley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C B Whitley. C B Whitley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simon, Katherine E., Alejandra Mondino, Beth Case, et al.. (2025). Quantifying placebo and trial participation effects on cognitive outcome measures in aging dogs. GeroScience. 47(6). 6909–6926.
2.
Simon, Katherine E., Alejandra Mondino, Beth Case, et al.. (2024). A randomized, controlled clinical trial demonstrates improved owner-assessed cognitive function in senior dogs receiving a senolytic and NAD+ precursor combination. Scientific Reports. 14(1). 12399–12399. 6 indexed citations
3.
Eisengart, Julie B., Kelly King, Elsa Shapiro, C B Whitley, & Joseph Muenzer. (2019). The nature and impact of neurobehavioral symptoms in neuronopathic Hunter syndrome. Molecular Genetics and Metabolism Reports. 22. 100549–100549. 28 indexed citations
4.
Shapiro, Elsa, Kelly King, Alia Ahmed, et al.. (2016). The neurobehavioral phenotype in mucopolysaccharidosis Type IIIB: An exploratory study. Molecular Genetics and Metabolism Reports. 6. 41–47. 34 indexed citations
5.
Ahmed, Alia, Kyle Rudser, Alicia Kunin‐Batson, et al.. (2015). Mucopolysaccharidosis (MPS) Physical Symptom Score: Development, Reliability, and Validity. JIMD Reports. 26. 61–68. 6 indexed citations
6.
Orchard, Paul J., C B Whitley, James M. Berry, et al.. (2012). Cardiac Ultrasound Findings in Infants with Severe (Hurler Phenotype) Untreated Mucopolysaccharidosis (MPS) Type I. JIMD Reports. 10. 87–94. 11 indexed citations
7.
Wolf, Daniel, Zhenhong Nan, Elizabeth Braunlin, et al.. (2011). Increased longevity and metabolic correction following syngeneic BMT in a murine model of mucopolysaccharidosis type I. Bone Marrow Transplantation. 47(9). 1235–1240. 5 indexed citations
8.
Polgreen, Lynda E., Jakub Tolar, John H. Himes, et al.. (2008). Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation. Bone Marrow Transplantation. 41(12). 1005–1011. 62 indexed citations
9.
Tolar, Jakub, Kendra Bjoraker, C B Whitley, et al.. (2007). Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome. Bone Marrow Transplantation. 41(6). 531–535. 99 indexed citations
10.
Waldek, S., Maryam Banikazemi, Jan Bultas, et al.. (2007). Clinical benefits of early treatment with Fabrazyme in Fabry disease. Clinical Therapeutics. 29. S29–S29. 2 indexed citations
11.
Braunlin, Elizabeth, et al.. (2000). Radiological Case of the Month. Archives of Pediatrics and Adolescent Medicine. 154(8). 841–841. 7 indexed citations
12.
Pan, Dao, Elena L. Aronovich, R. Scott McIvor, & C B Whitley. (2000). Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I. Gene Therapy. 7(21). 1875–1883. 13 indexed citations
13.
Aronovich, Elena L., Deng Pan, & C B Whitley. (1996). Molecular genetic defect underlying alpha-L-iduronidase pseudodeficiency.. PubMed. 58(1). 75–85. 34 indexed citations
14.
Jónsson, Jón J., Elena L. Aronovich, Stephen E. Braun, & C B Whitley. (1995). Molecular diagnosis of mucopolysaccharidosis type II (Hunter syndrome) by automated sequencing and computer-assisted interpretation: toward mutation mapping of the iduronate-2-sulfatase gene.. PubMed. 56(3). 597–607. 37 indexed citations
15.
Silvestri, Gabriella, Filippo M. Santorelli, Sara Shanske, et al.. (1994). A new mtDNA mutation in the tRNALeu(UUR) gene associated with maternally inherited cardiomyopathy. Human Mutation. 3(1). 37–43. 141 indexed citations
17.
18.
Whitley, C B, et al.. (1989). Diagnostic test for mucopolysaccharidosis. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion.. Clinical Chemistry. 35(3). 374–379. 179 indexed citations
19.
Whitley, C B, Kumar G. Belani, Richard K. Sibley, et al.. (1988). Resolution of obstructive sleep apnea in Hurler syndrome after bone marrow transplanation. International Journal of Pediatric Otorhinolaryngology. 15(1). 23–31. 22 indexed citations
20.
Tuchman, M, et al.. (1984). Determination of Urinary Succinylacetone by Capillary Gas Chromatography. Journal of Chromatographic Science. 22(5). 211–215. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026